Emily Wheeler is vice president of infectious disease policy at the Biotechnology Innovation Organization and director of Working to Fight AMR.
Doctors — and patients — need new antibiotics. But a broken market can't deliver them.
Legislative solutions can incentivize research and development for lifesaving antimicrobials.